Mechanistically, these pathogens may activate the NLRP3 inflammasome and induce IL-1β secretion by increasing the concentration of LPS in the host microenvironment, thereby promoting insulin resistance in T2DM patients. Here, NLRP3 is linked to type 2 diabetes mellitus.